Full metadata record
DC FieldValueLanguage
dc.contributor.authorChang, Y-Wen_US
dc.contributor.authorMai, R-Ten_US
dc.contributor.authorFang, W-Hen_US
dc.contributor.authorLin, C-Cen_US
dc.contributor.authorChiu, C-Cen_US
dc.contributor.authorLee, Y-H Wuen_US
dc.date.accessioned2014-12-08T15:36:55Z-
dc.date.available2014-12-08T15:36:55Z-
dc.date.issued2014-10-23en_US
dc.identifier.issn0950-9232en_US
dc.identifier.urihttp://dx.doi.org/10.1038/onc.2013.450en_US
dc.identifier.urihttp://hdl.handle.net/11536/25324-
dc.description.abstractY-box binding protein-1 (YB-1) is highly expressed in tumors and it participates in various cellular processes. Previous studies indicated that YB-1 binds to mispaired DNA and interacts with several mismatch repair (MMR)-related factors. However, its role in the MMR system remains undefined. Here, we found that YB-1 represses mutS homolog 6 (MSH6)-containing MMR complex formation and reduces MutS alpha mismatch binding activity by disrupting interactions among MMR-related factors. In an effort to elucidate how YB-1 exerts this inhibitory effect, we have identified two functional proliferating cell nuclear antigen (PCNA)interacting protein (PIP)-boxes that mediate YB-1/PCNA interaction and locate within the C-terminal region of YB-1. This interaction is critical for the regulatory role of YB-1 in repressing MutSa mismatch binding activity, disrupting MutS alpha/PCNA/G/T heteroduplex ternary complex formation and inhibiting in vitro MMR activity. The differential regulation of 3\' and 5\' nick-directed MMR activity by YB-1 was also observed. Moreover, YB-1 overexpression is associated with the alteration of microsatellite pattern and the enhancement of N-methyl-N\'-nitro-N-nitrosoguanidine (MNNG)-induced and spontaneous mutations. Furthermore, upregulation of other PIP-box-containing proteins, such as myeloid cell leukemia-1 (Mcl-1) and inhibitor of growth protein 1b (ING1b), has no impact on MMR complex formation and mutation accumulation, thus revealing the significant effect of YB-1 on regulating the MMR system. In conclusion, our study suggests that YB-1 functions as a PCNA-interacting factor to exert its regulatory role on the MMR process and involves in the induction of genome instability, which may partially account for the oncogenic potential of YB-1.en_US
dc.language.isoen_USen_US
dc.titleYB-1 disrupts mismatch repair complex formation, interferes with MutS alpha recruitment on mismatch and inhibits mismatch repair through interacting with PCNAen_US
dc.typeArticleen_US
dc.identifier.doi10.1038/onc.2013.450en_US
dc.identifier.journalONCOGENEen_US
dc.citation.volume33en_US
dc.citation.issue43en_US
dc.citation.spage5065en_US
dc.citation.epage5077en_US
dc.contributor.department生醫工程研究所zh_TW
dc.contributor.departmentInstitute of Biomedical Engineeringen_US
dc.identifier.wosnumberWOS:000343768400002-
dc.citation.woscount0-
Appears in Collections:Articles